DP Technology Secures Tens of Millions in Series B Funding to Lead the AI+Molecular Simulation Industry

Recently,DP TechnologyDP Technology Completed Tens of Millions of Dollars in Series B Financing, this round of financing was led bySource Code Capital and Qiming Venture Capital jointly led the investment, with existing shareholders such as Hillhouse Ventures and Matrix Partners continuing to increase their investments.，Miracle Capital served as the exclusive FA for this round of financing.This round of financing is the fourth round of financing completed by DP Technology within 18 months.

The deep integration of AI + Science introduces new production tools and a paradigm-shifting scientific model into the research and development horizon.DP Technology, as a pioneer in the AI+Science research paradigm, has once again gained the support and trust of its investment partners with its solid research capabilities and industrial implementation.

Recently,DP Technology Completes Tens of Millions of Dollars in Series B Financing, this round of financing was led bySource Code Capital and Qiming Venture Capital jointly led the investment`, Old Shareholders`GL Ventures, Matrix Partners China Continue to Increase Investment，Miracle Capital served as the exclusive FA for this round of financing.。The funds from this round of financing will be used to continuously attract top talents in the industry, deepen the implementation and improvement of the micro-scale industrial design platform, and maintain long-term investment in technical directions such as drug and material design.

This is DP Technology inWithin 18 monthsContinuously CompletedFour Rounds of FinancingPreviously, DP Technology completed several rounds of financing: a Series A round worth tens of millions of dollars led by Hillhouse Ventures with participation from Matrix Partners and BioMap; a Pre-A round led by Vision Plus Capital with participation from Clearflow Capital; and an angel round led by Baidu Ventures with participation from Weili Capital and Shengjing Jicheng. The continuous support from investors demonstrates the market's sustained confidence in DP Technology’s development.

Thank you to our investment partners for their recognition and participation in the development process of DP Technology. DP Technology will continue to accelerate the implementation of the microscale industrial design platform, innovate and explore within the AI + Science vision, and build a new generation of productivity tools for fields such as pharmaceuticals, materials, and new energy, while constructing computational power infrastructure.

Sun Weijie, founder and CEO of DP Technology, said:AI + Science as a new R&D paradigm has become a hot topic in the field. We, as practitioners, should continuously define and solve key industry problems, expand the boundaries of technological productivity, and use all advanced computational methods to improve the efficiency of computational simulations. We must quickly transform the R&D in the micro-scale industrial field from large-scale trial-and-error experiments into a new paradigm of "computational design - experimental validation," providing micro-scale industrial design infrastructure for the advancement of human civilization.

Whether in academia or industry, AI is deeply involved in the development and progress of fundamental scientific fields such as biology, chemistry, physics, and engineering, pushing the boundaries of human cognition in unprecedented ways. After DP Technology's AI + molecular simulation technology won the Gordon Bell Prize in 2020, its capabilities have now expanded to...Efficient Calculation of Billions of Atoms at Quantum Mechanical PrecisionDP Technology has launched a range of simulation tools from fundamental mathematical models to computer science-based simulation tools, meeting the diverse simulation R&D needs in fields such as chemistry, biology, and materials.Lebesgue Scientific Computing Platform、Hermite Drug Design PlatformandBohrium Microscopic Computing and Design Platform, forming the microscale industrial design platform matrix of DP Technology.

Through these high-performance new productivity tools, DP Technology is committed to unleashing the productive forces in scientific research and industrial design, and accelerating the transformation and upgrading of traditional industries. Currently, DP Technology's strong research capabilities and industry implementation are gradually being demonstrated, having already partnered with several top clients in pharmaceuticals, materials, new energy, and other fields. Empowered by a microscale industrial design platform, they are building a complete system from foundational innovation to industrial implementation.

In the new energy field, DP Technology has reached a cooperation with CATL to build a joint laboratory, driving material research and development with more efficient computing to jointly expand the future space for cutting-edge technology development in the new energy sector. In the pharmaceutical field, DP Technology collaborates with multiple clients, integrating physical modeling + AI computing paradigms into preclinical drug discovery. Through modules such as Hermite Uni-FEP, Uni-Fold, and RiD, which combine free energy perturbation theory, molecular dynamics, enhanced sampling algorithms, and high-performance computing, DP Technology accurately predicts protein structures and conformational changes. It also efficiently evaluates the binding free energy of proteins and ligands with chemical precision, providing drug researchers with efficient and accurate theoretical guidance to enhance the efficiency of drug design and optimization.

At the same time, DP Technology gains deep insights into the new demands for computing power in the cloud-native era and designs solutions. Based on "(Physical Model + AI) * (HPC + Cloud)," it builds the Lebesgue scientific computing platform, bridging the "last mile" between scientific computing and massive computing power.

The two major basic research paradigms of scientific research provide substantial developmental momentum for research and computation through different pathways. However, "seeing the big picture from a single leaf" is overly idealistic, while "panning for gold in the sand" is cumbersome and inefficient. The trade-off between precision and speed causes a single research paradigm to gradually lose effectiveness in certain fields.

AI + Science: The combination of AI's complex data processing capabilities and Science's first principles essentially represents the integration of two traditional research paradigms. DP Technology uses AI to bridge different scales, continuously pushing the accuracy of first principles towards the macro world, opening the door to a new paradigm of scientific research and practical application scenarios.

In 2021, DP Technology released Uni-Fold, a protein structure prediction tool. Along with open-sourcing the training and inference code, the corresponding solution was integrated into Hermite, DP Technology's self-developed drug design platform, sparking lively discussions in both academic and industrial circles. This marks DP Technology's practical application in structural biology under the vision of AI + Science. DP Technology is also rigorously exploring other fields, with rich and broad application opportunities for AI + Science in scenarios such as drug design, materials, and batteries.

DP Technology is building a microscale industrial design platform and computing power infrastructure, which is an effort to deeply construct large-scale engineering of AI + Science. As each business line continues to become more structured and standardized, DP Technology's team is also growing. In the future, DP Technology will continue to base itself on the AI + Science research paradigm, constantly improving industrial software and service systems applicable to different fields such as materials, pharmaceuticals, and new energy. DP Technology hopes to use its technological advantages to effectively empower these industries that are closely related to human civilization.

Dr. Chen Kan, Partner of Qiming Venture Partners, said：

"Artificial intelligence accelerates the emergence of new paradigms in scientific research. DP Technology's breakthrough AI + quantum simulation cross-scale modeling has overcome the bottlenecks of traditional molecular simulations, enabling the creation of multi-field demand solutions. Currently, DP Technology's software platform is widely used in multidisciplinary laboratories in academia. With its unique technical advantages and star team support, we look forward to DP Technology becoming a world-leading 'next-generation' molecular simulation platform based in China."

Huang Yungang, partner of Source Code Capital, said:

"DP Technology is dedicated to building a computational tool platform for a new research and development paradigm, empowering industries such as pharmaceuticals and materials more effectively. For instance, in the biomedicine sector—one of the key areas—scientific computing is driving industry progress. Meanwhile, the investment philosophy and practice of 'technology + biomedicine' from Source Code Capital continue to inject cross-disciplinary consensus into the medical and biological fields. We highly anticipate that the company will significantly enhance R&D efficiency across the industry."

At DP Technology, the future we see is:Everything in the world with complete physical definitions will be solvable by agile models and massive computing power..AI + Science, as a revolutionary research paradigm, will be the only path to this future.

2022 marks the third year since the founding of DP Technology. Over the past three years, DP Technology has consistently adhered to the vision of "technology for good," employing AI + Science as its research paradigm, focusing on the microscale, and exploring vast new frontiers. "The Future of Molecular Simulation" is not just a slogan but a genuine vision that DP Technology aims to realize. We look forward to gathering more like-minded partners to join forces with DP Technology in accumulating strength and moving forward with determination.

DP Technology, the pioneer in envisioning the future and transforming it into the present.

DP Technology was founded in 2018 and embarked on a path of scaled development in 2019, dedicated to solving micro-scale industrial design challenges with next-generation molecular simulation technology. Its main business direction is to create a simulation R&D platform that effectively serves pharmaceutical companies, material suppliers, and research institutions, with the primary goal of liberating the productivity of R&D workers.

DP Technology has strong scientific research and industrial implementation capabilities. Its self-developed algorithm, Deep Potential, maintains the accuracy of quantum mechanics while increasing the computational speed of molecular dynamics by several orders of magnitude. Combined with high-performance computing, it can perform quantum mechanics-precision calculations and simulations on systems with billions of atoms. The core team members received the 2020 Gordon Bell Prize, the highest award in the global high-performance computing field, and their work was selected as one of China's top ten scientific advances in 2020 and one of the ten major technological breakthroughs in the global AI field.